Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunotherapy
Researchers from University of Florida, Department of Urology publish findings in immunotherapy
October 22nd, 2008
Scientists discuss in 'Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions' new findings in immunotherapy. According to recent research from the United States, "The objective of this study was to develop a scalable and broadly applicable active immunotherapy approach against cancer, circumventing the limitations typically encountered with autologous vaccination strategies. We hypothesized that human embryonic stem cells (hESC) can serve as a virtually unlimited source for generating dendritic cells (DC) with potent antigen-presenting function." "Here, we investigated the developmental processes and...
Source: Vaccine Weekly (2008-10-22)
|
